|
|
||||||||
1 Department of Microbiology, Oregon State University, Corvallis, 97331
2 Department of Biotechnology, University of New South Wales, Sydney, Australia
3 DSM Food Specialties, Moorebank, New South Wales, Australia
Corresponding author: Bruce L. Geller; e-mail: gellerb{at}orst.edu.
| ABSTRACT |
|---|
|
|
|---|
Key Words: Lactococcus lactis phage phage attachment
Abbreviation key: BisTris =bis [hydroxyethyl] iminotris [hydroxymethyl] methane, EGTA = ethyleneglycolbis- (ß-aminoethyl ether) N, N, N', N'-tetraacetic acid,
-GP = DL-
-glycerophosphate
| INTRODUCTION |
|---|
|
|
|---|
One strategy that improves phage resistance of L. lactis is to genetically delete expression of the Pip protein (Garbutt et al., 1997; Kraus and Geller, 1998). Pip is a host-encoded receptor for c2 species phage, which is 1 of the 3 lactococcal phage species (Jarvis et al., 1991; Brussow, 2001) that predominate in cheese factories. Pip apparently is not a receptor for the other 2 lactococcal phage species (936 and P335). If a similar strategy of improving resistance to 936 and P335 phages were possible, then identifying the mechanism by which these phage attach to the bacterial cell surface would help in designing genetic tactics for removing or modifying cell surface phage receptors.
Phage receptors on gram-positive bacteria are usually associated with nonproteinaceous components of the cell wall (Beumer et al., 1984; Valyasevi et al., 1990; Estrela et al., 1991; Schafer et al., 1991; Valyasevi et al., 1994; Quiberoni et al., 2000). Pip is an exception to the norm for gram-positive phage receptors. Other than S-layer or flagellar proteins, it is the only known plasma membrane-associated protein that acts as a phage receptor on gram-positive bacteria (Archibald, 1980). But even c2-species lactococcal phage apparently adsorb to carbohydrate receptors before or concurrently with Pip (Monteville et al., 1994). It appears that multiple receptors for a single phage are common among gram-positive bacteria (Archibald, 1980). The cell wall receptors for two 936-species lactococcal phages, sk1 and kh, have been partially characterized (Valyasevi et al., 1990, 1994). Both include rhamnose and other sugars commonly found in the cell wall of L. lactis. Recently, genes involved in the synthesis of cell wall carbohydrate have been identified and found to be required for adsorption of 936-species phages bIL170 and
645 (Dupont et al., 2004a).
This report presents biochemical data that attachment to the lactococcal surface of a 936 species phage (sk1) is to the cell wall only and not to a membrane protein. The report confirms that calcium (Collins et al., 1950; Sozzi, 1972) is not required for adsorption and inactivation of phage sk1 by cell walls.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation and Purification of Plasma Membrane, Cell Wall, and Cell Envelope
Plasma membrane and cell wall from L. lactis LM0230 were isolated as described (Valyasevi et al., 1991), including hot SDS treatment of envelopes to remove plasma membrane. Plasma membrane from E. coli HB101 was isolated by the lysozyme-EDTA method of Kaback (Kaback, 1971; Short et al., 1975), and further purified on the optional 2-step sucrose gradient. Envelopes were prepared as described (Valyasevi et al., 1990), except that cells were resuspended to 67 rather than 150 mg/mL, glass beads were removed by centrifugation instead of filtration, and the SDS treatment was replaced with 2 centrifugations at 1400 x g, 5 min, 4°C, from L. lactis C2 (pip). Lactococcus lactis C2 (pip) has a site-specific ochre mutation in pip and was constructed as described (Kraus and Geller, 2001) using strain C2, which is the wild-type strain from which LM0230 is derived. Plasma membrane, cell wall, and envelope preparations were quantified by measuring total phosphate (Ames, 1966), protein (Bradford, 1976; BSA as standard), and sugar (DuBois et al., 1956; glucose as standard). Plasma membrane had protein: phosphate = 36 to 71 mg/mmol and protein: sugar = 0.2 to 0.6 mg/mg. Cell walls had a protein: sugar = 0.1 mg/mg. Envelopes had a protein: sugar = 0.1 to 0.3 mg/mg.
Phage Inactivation
In a final volume of 25 µL of 100 mM (bis[hydroxyethyl] iminotris [hydroxymethyl] methane) (BisTris)/1 mM CaCl2 (pH 6.8), approximately 2.5 x102 plaque-forming units (pfu) were mixed on ice with or without plasma membrane, cell wall, envelope, or whole cells. The final concentration of membrane, cell wall, or envelope was equivalent to 100 mM phosphate, 70 mM glucose, or 15 mM glucose, respectively, unless otherwise indicated. Whole cells from 0.5 mL of an overnight culture were washed 3 times in 0.5 mL of 100 mM BisTris, pH 6.8 and resuspended in same buffer to 0.5 mL. Washed cells (0.5 µL) were mixed with phage and incubated 2 to 4 h on ice. The phage titer was determined using duplicate 10-µL aliquots. Inactivation of phage was calculated by dividing the average phage titer of the sample with membrane or cell wall by the average phage titer of a similar mixture without membrane or cell wall, subtracting the quotient from 1, and multiplying by 100.
Phage Adsorption
Phage were mixed with membrane, cell wall, envelope, or washed whole cells and incubated as described above for inactivation. Following incubation, the mixture was centrifuged at 17,000 x g, 5 min, 4°C, and the supernatant was removed. The phage titer of the supernatant was determined in duplicate. The percentage of bound phage was calculated by dividing the titer of the supernatant by the titer of the mixture before centrifugation, subtracting from 1, and multiplying by 100.
Treatment of Membrane, Cell Wall, and Envelope
Purified plasma membrane was diluted to 0.5 mM phosphate equivalent in 100 µL of 2 M KCl/100 mM BisTris pH 6.8, 8 M urea/100 mM BisTris pH 6.8, or 100 mM Na2CO3/pH 11 and incubated on ice for 3 h. The membranes were collected by centrifugation (20,000 x g, 10 min, 4°C), washed in 100 µL of BisTris pH 6.8, suspended to 2.5 mM phosphate equivalent in 100 mM BisTris pH 6.8, and tested for inactivation of phage as described above. Recovery of membranes was equivalent for all treatments, as determined by total phosphate analysis.
Purified plasma membrane was diluted to 2.5 mM phosphate equivalent in 21 µL of 100 mM BisTris pH 6.8. Trypsin, chymotrypsin, pepsin, papain, or proteinase K was added to final concentrations of 1 mg/mL. Alternatively, membrane was diluted to 1 to 2 mM phosphate equivalent and mixed with either 25 units of mutanolysin (Boehringer, Germany, or Sigma Chemical Co., St. Louis) or 15 mg/mL lysozyme (Sigma Chemical Co.). Controls without enzyme but with membrane, or without membrane but with enzyme were included. Mixtures were incubated 1 to 2 h at 37°C. Phenylmeth-ylsulfonyl fluoride (1 mM) was added to the mixtures with trypsin, chymotrypsin, and proteinase K and incubated for 30 min at 37°C. The treated membranes were tested for inactivation of phage as described above.
Cell wall was diluted in 50 mM Tris-HCl, pH 8.0 to 18 mM glucose equivalent, mixed with a final concentration of 20 mg/mL lysozyme or 50 units of mutanolysin, and incubated at 37°C for 2 h. Treated cell walls were isolated by centrifugation (10,000 xg, 10 min, 4°C), washed twice in one volume, and resuspended in 50 mM Tris-HCl, pH 8.0.
Aliquots (0.5 mL) of isolated envelopes (4 mM glucose equivalent) were boiled with or without 0.1% SDS for 10 min. A control aliquot (0.5 mL) without SDS was not boiled. Envelopes were washed 3 times in 1 mL of either 0.1% SDS (aliquot treated with SDS), H2O (boiled aliquot), or 10 mM BisTris, pH 6.8 (not boiled), and isolated by centrifugation at 17,900 xg, 10 min, 20°C. Following this, envelopes were washed 3 times in 30 mL of H2O, and collected by centrifugation as described above. Finally, treated and washed envelopes were re-suspended in 0.5 mL of 10 mM BisTris, pH 6.8.
Inhibitors of Inactivation
The following substances were added to the phage inactivation assay at a final concentration of 100 mM: DL-
-glycerophosphate (
-GP; pH 6.8), glycerol, K2HPO4 (pH 6.8), Na2HPO4 (pH 6.8), D-glucose, D-galactose, D-alanine, rhamnose, o-phosphorylethanolamine, N-acetylglucosamine, and ethyleneglycolbis-(ß-aminoethyl ether) N,N,N',N'- tetraacetic acid (EGTA, pH 7.0). Controls without membrane or cell wall, but with inhibitor, were used to calculate the percentage inhibition.
Lipoteichoic acid (Biotrend, Chemikalien GmbH, Cologne, Germany) or antiteichoic acid monoclonal antibody (clone 55, HyCult Biotechnology BV, Uden, the Netherlands) was added to the phage inactivation assay at a final concentration of 20 or 0.4 µg/mL, respectively.
Phage DNA Ejection
Phage sk1 was labeled with [3H] thymidine (Amersham Biosciences, Piscataway, NJ) as described (Monteville et al., 1994) with the following exceptions: washed cells were subcultured by diluting 4 x103 into 6 mL of SLSD medium supplemented with 24 µCi of [3H] thymidine. When the culture reached an optical density (600 nm) of ~0.35, CaCl2 (10 mM), 18 µCi of [3H] thymidine, and phage sk1 (multiplicity of infection = 2) were added.
Membranes (1 mM phosphate equivalent), walls (7.2 mM glucose equivalent), or envelopes (1 mM glucose equivalent) were mixed with 2 x108 pfu of [3H] phage sk1 (2 x106 cpm/pfu) in 25 µL of 100 mM BisTris-HCl, 5 mM CaCl2, pH 6.8 or 100 mM BisTris-HCl, 10 mM EDTA, pH 6.8. Mixtures were incubated on ice for 2 h. Samples (2 µL) of each mixture were diluted in M17 broth and the phage titer was determined. To the remainder of each mixture was added MgCl2 (20 mM) and 10 units (4 µg) of bovine pancreas deoxyribonuclease I (Sigma Chemical Co.). The mixture was digested for 1.5 h at 37°C. Bovine serum albumin (40 µg/mL), salmon sperm DNA (40 µg/mL), and trichloroacetic acid (10%) were added, and the mixture was incubated on ice for 15 min. Half of the volume was removed and transferred to a liquid scintillation vial. The other half was centrifuged at 16,000 xg, 10 min, 4°C. The supernatant was removed and transferred to a liquid scintillation vial (trichloroacetic acid-soluble). The pellet was resuspended in 40 µL of 100 mM BisTris, pH 6.8 and transferred to a liquid scintillation vial (trichloroacetic acid-insoluble).
| RESULTS |
|---|
|
|
|---|
Cell Wall Inactivates Phage sk1
Cell wall from strain LM0230 was prepared from envelope by removing the plasma membrane with detergent. Cell wall was mixed and incubated with phage sk1, jj50, or 64. Phage sk1, jj50, and 64 were inactivated 99 (SD = 1, n = 5), 80 (SD = 20, n = 2), and 96% (SD = 3, n = 2), respectively. Phages kh and P008 were inactivated 3 (SD = 4, n = 2) and 0% (SD = 0, n = 2), respectively.
Cell wall was treated with a lysozyme or mutanolysin and mixed with phage sk1. Lysozyme-treated cell wall inactivated 84% (SD = 15, n = 3) of phage sk1, whereas mutanolysin-treated wall inactivated 0% (SD = 0, n = 2) of the phage. Extending the lysozyme treatment from 2 to 24 h had no significant effect on the results.
A Role for Plasma Membrane in Phage sk1 Inactivation?
Although the above results showed that cell walls without plasma membrane were sufficient to inactivate phage sk1, we hypothesized that plasma membrane may also inactivate phage sk1, which is the case for phage c2. Plasma membrane from L. lactis LM0230 was mixed with either phage sk1 (species 936) or phage c2 (species c2) and incubated on ice. The phage titer of each mixture was measured. Plasma membrane reduced the phage titer by 95 and 93% for phage sk1 and c2, respectively (Table 1
, no pretreatment). No inactivation of phage sk1 was found in mixtures that contained plasma membrane from E. coli instead of L. lactis. Plasma membrane also inactivated phages jj50 and 64 by 72 and 97%, respectively (Table 1
).
|
The loss of inactivation of phage after treatment of membrane preparations with mutanolysin correlated with loss of phage sk1 adsorption. Mutanolysin-treated membrane was mixed and incubated with phage sk1. Following incubation, the mixture was centrifuged to remove membrane-bound phage. The titer of the supernatant after centrifugation was 100% (SD = 0.7, n = 2) of the titer of the mixture before centrifugation. This result showed that cell wall fragments, which apparently copurified with plasma membrane, are required in the membrane preparation for in vitro inactivation of phage sk1.
If plasma membrane plays any role in the in vitro inactivation of phage sk1, then treating the membrane preparation (including the apparent cell wall fragments) with reagents that either destroy or mimic membrane components might reduce the inactivation. We first tested this by washing the membrane preparation in 2 M KCl, pH 11 buffer, or 8 M urea, which disrupt noncovalent bonds and dissociate weakly bound material. After treatment, membrane was reisolated by centrifugation and resuspended in pH 6.8 buffer. Treated membrane was mixed and incubated with phage sk1. None of the treatments reduced the inactivation of phage by the membrane preparation (Table 1
).
Heat- or Protease-Treated Plasma Membrane
Isolated plasma membrane was incubated at 100°C for 15 min before cooling to 0°C and mixing with phage sk1. Boiling did not reduce the effect on phages sk1, jj50, or 64, but abolished the ability of plasma membrane to inactivate phage c2, which requires the membrane protein Pip as a receptor (Table 1
).
Isolated plasma membrane was mixed and incubated with proteinase K, trypsin, or chymotrypsin. Protease inhibitors were added, and the proteolyzed membrane was mixed and incubated with phage. Protease-treated membrane inactivated phage sk1, jj50, or 64 to the same extent as the untreated controls, but did not inactivate phage c2 (Table 1
). Proteases or protease inhibitors without membranes did not inactivate the phages (data not shown).
Inhibition of Inactivation
Various chemicals that resemble components of the plasma membrane or peptidoglycan were mixed and incubated with plasma membrane and phage sk1.
-Glycerophosphate inhibited inactivation of the phage by the membrane (Table 2
). Glycerol, Na2HPO4, D-alanine, N-acetylglucosamine, rhamnose, glucose, galactose, or o-phosphorylethanolamine had no effect.
-Glycerophosphate is part of the structure of lipoteichoic acid, and might act like a competitive inhibitor. These results suggested that lipoteichoic acid might participate in the inactivation of phage sk1.
|
Antiserum to lipoteichoic acid was included in a mixture of membrane and phage sk1. Phage sk1 was inactivated 100 (SD = 0.7, n = 2) and 98% (SD = 2.1, n = 2) with antiserum against lipoteichoic acid or with nonimmune serum, respectively. These results show that lipoteichoic acid did not inactivate phage sk1 or block inactivation.
-GP and Calcium
The inhibitory effect of
-GP may be linked to its ability to bind or precipitate calcium, which is required for phage sk1 infection. This was tested by adding an excess of calcium to a mixture of phage sk1 and membrane. The results showed that excess calcium reversed the effect of
-GP (Figure 1
).
|
The adsorption of phage sk1 to cell wall, lysozyme-treated cell wall, or whole cells was measured in mixtures without Ca2+. Cell walls bound 95 (SD = 7, n = 3), lysozyme-treated cells walls 86 (SD = 10, n = 2), and whole cells 100% (SD = 0, n = 2) of the phage. This result showed that calcium is not required for adsorption to cell wall in vitro or to intact cells.
The above results showed that lysozyme treatment changed the mechanism of phage inactivation to one that requires calcium. However, the latent requirement for calcium did not correlate with adsorption of phage to cell wall or lysozyme-treated cell wall.
Phage sk1 DNA Ejection
The nature of inactivation was characterized by measuring the ejection of phage sk1 DNA from the capsid. [3H] Thymidine-labeled phage sk1 was mixed with membrane, wall, or envelope. After 2 h, the phage titer was measured and the amount of ejected DNA was analyzed by accessibility to deoxyribonuclease. As expected, each cellular fraction inactivated nearly all the phage (Table 3
). Moreover, phage DNA became accessible to nuclease in all mixtures except controls without membrane, wall, or envelope. Similar results were found with or without calcium in the mixture (Table 3
).
|
| DISCUSSION |
|---|
|
|
|---|
In this report, we have shown that host cell wall is necessary and sufficient for adsorption and irreversible inactivation of 936 species phages sk1, jj50, and 64. However, because both a membrane protein (Pip) and the cell wall participate in adsorption of another species (c2) of lactococcal phages (Monteville et al., 1994), plasma membranes were analyzed further for a role in phage sk1 adsorption and inactivation.
Heat or protease treatment of membrane preparations (which apparently included cell wall fragments) did not decrease the ability of the preparation to inactivate phages sk1, jj50, or 64. Other treatments with protein denaturants also had no effect on phage sk1. These results suggest that membrane or cell wall proteins are not required for inactivation, although involvement of an unusually stable protein cannot be eliminated.
-Glycerophosphate significantly reduced inactivation of phage sk1 by membrane preparations (Table 2
). Neither glycerol nor phosphate had any inhibitory effect on membrane inactivation of phage sk1. This suggested that
-GP might mimic part of the phage receptor, thereby preventing phage sk1 from irreversibly adsorbing to the membrane. Lactococcus lactis membrane is composed in part by 2 types of molecules that have
-GP as part of their structures: phospholipids and lipoteichoic acid (Wicken and Knox, 1975). Lactococcus lactis apparently lacks wall teichoic acid (Schleifer and Kandler, 1967; Johnson and McDonald, 1974; Valyasevi et al., 1990). Previous work has shown that galactosyl-containing lipoteichoic acid blocks adsorption of a related lactococcal phage, although galactosyl-lipoteichoic acid did not bind phage sk11G (Sijtsma et al., 1990). We hypothesized that lipoteichoic acids might be part of a receptor for species 936 phages. However, neither pure lipoteichoic acid nor antiserum to lipoteichoic acid had any effect on inactivation of phage sk1. This suggests that lipoteichoic acid is not involved in the inactivation of phage sk1 in vitro, and further supports the conclusion that a membrane component does not participate in adsorption or inactivation of phage sk1. Membranes from E. coli failed to inactivate phage sk1, which indicates that phospholipids are not sufficient.
The similar inhibitory effects of
-GP and EGTA, a chelator of divalent cations, suggested that
-GP inhibited phage inactivation by effectively removing calcium from the mixture. Indeed, phage-inhibitory growth media for commercial strains of L. lactis include a variety of phosphate-containing compounds that bind calcium (Sozzi, 1972; Gulstrom et al., 1979; Sandine, 1979). This suggestion was shown to be correct by reversing the effect of
-GP with an excess of calcium (Figure 1
).
Although calcium is required for plaque formation of phage sk1 in vivo, we were able to show calcium-dependency of inactivation in vitro only with cell walls or plasma membrane that apparently had been partially hydrolyzed with lysozyme, but not with intact cell walls or envelope. Lysozyme from hen is known not to hydrolyze O-acetylated muramyl subunits (Holtje, 1996), and may leave intact some of the peptidoglycan of L. lactis. Additional treatment (postisolation) of plasma membrane with lysozyme or another muramidase (mutanolysin), which hydrolyzes the same bond as lysozyme but recognizes both N- and O-acetylated glucos-amine (Holtje 1996), eliminated the activity of plasma membrane. This suggests that inactivation of species-936 phages such as sk1, jj50, and 64 by membrane preparations was caused by cell wall fragments that copurified with the membranes. The significance of the calcium-dependency for inactivation and the requirement for lysozyme treatment to expose this dependency remains uncertain. Nevertheless, calcium was not required for adsorption to cells, cell walls, or lysozyme-treated cell wall. This shows that calcium is required for a step subsequent to adsorption of phage to the cell wall.
The requirement for calcium in phage infections of Lactobacillus or E. coli has been investigated. Calcium is not required for adsorption of phages of Lactobacillus delbrueckii (Quiberoni et al., 2004), Lactobacillus casei (Watanabe and Takesue, 1972), or phage T5 to E. coli (Bonhivers and Letellier, 1995). Its role in phage infection appears linked to maintaining an energized plasma membrane by resealing the membrane after phage DNA injection into the host (Watanabe and Takesue, 1973; Watanabe et al., 1979; Bonhivers and Letellier, 1995). There has also been a suggestion that calcium stabilizes the coiled DNA inside the phage capsid (Sechaud et al., 1988). We showed here that inactivation results from ejection of phage DNA. Furthermore, our results suggest that calcium is not required for ejection. However, because addition of magnesium was required (for deoxyribonuclease) during analysis of the ejected DNA, it is possible that magnesium substituted for calcium and ejection occurred only after magnesium was added.
Theoretically, phage must interact closely with the plasma membrane during infection, to inject the phage genome into the host cell without exposing its DNA to the environment. Indeed, we have confirmed (unpublished results) that deoxyribonuclease has no effect on phage sk1 titer when added to a mixture of phage and indicator strain immediately before infection. However, the ejection of phage DNA upon contact with cell wall in vitro suggests that additional controls must exist in vivo to coordinate intimate association between phage and plasma membrane. We speculate that in vivo, the cell wall receptor positions the phage tail and enables phage tail proteins to form a channel through which phage DNA traverses the plasma membrane. Similar models have been proposed for phage
and T5 infections of E. coli (Roessner and Ihler, 1986; Feucht et al., 1990; Guihard et al., 1992).
The bottom line for applied microbiologists is that engineering of adsorption-defective strains for species 936 phage will probably require manipulation of host genes that control cell wall synthesis, some of which have already been identified (Dupont et al., 2004a). In addition, the recent identification of receptor-binding proteins in 936 species phages may provide new strategies for identifying host receptors and combating phage infections in commercial settings (Dupont et al., 2004b).
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication February 20, 2004. Accepted for publication October 28, 2004.
| REFERENCES |
|---|
|
|
|---|
DNA. J. Biol. Chem. 261:386390.This article has been cited by other articles:
![]() |
G. Sciara, S. Blangy, M. Siponen, S. Mc Grath, D. van Sinderen, M. Tegoni, C. Cambillau, and V. Campanacci A Topological Model of the Baseplate of Lactococcal Phage Tuc2009 J. Biol. Chem., February 1, 2008; 283(5): 2716 - 2723. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Spinelli, V. Campanacci, S. Blangy, S. Moineau, M. Tegoni, and C. Cambillau Modular Structure of the Receptor Binding Proteins of Lactococcus lactis Phages: THE RBP STRUCTURE OF THE TEMPERATE PHAGE TP901-1 J. Biol. Chem., May 19, 2006; 281(20): 14256 - 14262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Tremblay, M. Tegoni, S. Spinelli, V. Campanacci, S. Blangy, C. Huyghe, A. Desmyter, S. Labrie, S. Moineau, and C. Cambillau Receptor-Binding Protein of Lactococcus lactis Phages: Identification and Characterization of the Saccharide Receptor-Binding Site. J. Bacteriol., April 1, 2006; 188(7): 2400 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Vegge, F. K. Vogensen, S. Mc Grath, H. Neve, D. van Sinderen, and L. Brondsted Identification of the Lower Baseplate Protein as the Antireceptor of the Temperate Lactococcal Bacteriophages TP901-1 and Tuc2009 J. Bacteriol., January 1, 2006; 188(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |